Posted on 8/7/18
Onconova Therapeutics to Provide Corporate Update
NEWTOWN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat . . .
Posted on 8/17/18
Interview with Paula Swain, EVP of Human Resources at Incyte Corporation - Part III
Brought to you by Newmark Knight Frank
Posted on 8/14/18
Interview with Paula Swain, EVP of Human Resources at Incyte Corporation - Part II
Brought to you by Newmark Knight Frank
Posted on 8/9/18
Interview with Paula Swain, EVP of Human Resources at Incyte Corporation - Part I
Brought to you by Newmark Knight Frank
Posted on 8/6/18
Krystal Biotech Reports Second Quarter 2018 Financial Results and Provides Corporate Update
PITTSBURGH, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech (NASDAQ:KRYS), a gene therapy company advancing “off-the-shelf” topical and intra-dermal treatments for skin diseases, today reported financial . . .
Posted on 8/2/18
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to . . .
Posted on 8/2/18
Marinus Pharmaceuticals Provides Business Update
RADNOR, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and . . .
Posted on 8/1/18
Marks & Spencer Expands Partnership with First Insight
PITTSBURGH & LONDON--(BUSINESS WIRE)--First Insight, Inc., a global technology company transforming how leading retailers make product investment and pricing decisions, and Marks and Spencer (M&S), (LON: . . .
Posted on 7/31/18
AMETEK Acquires Motec GmbH
AMETEK, Inc. (NYSE: AME) today announced that it has completed the acquisition of Motec GmbH, a leading provider of integrated vision systems serving the high growth . . .
Posted on 7/31/18
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
RADNOR, Pa., July 30, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and . . .
Posted on 7/30/18
Johnson & Johnson Consumer To Acquire Zarbee's
Johnson & Johnson Consumer Inc. announced today that it has entered into a definitive agreement to acquire Zarbee's, Inc., a privately held company that is a . . .
Posted on 7/27/18
Idera Pharmaceuticals Announces One-for-Eight Reverse Stock Split
EXTON, Pa., July 27, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune . . .
Posted on 7/27/18
Nabriva Therapeutics Prices Public Offering of Ordinary Shares of Approximately $50M
DUBLIN, Ireland and KING OF PRUSSIA, Pa., July 26, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced the pricing of its underwritten public offering . . .
Posted on 7/22/18
Zynerba Pharmaceuticals Prices Public Offering of Common Stock
DEVON, Pa., July 20, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) today announced the pricing of an underwritten public offering of 4,062,500 shares of its . . .
Posted on 7/19/18
Idera Pharmaceuticals Provides Update On Corporate Strategy And Outlook
EXTON, Pa., July 16, 2018 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, . . .
Posted on 7/19/18
New Partnership Between Gastrologix and Stratis Medical Offer GI Practices a Smart Choice
Gastrologix, a gastroenterology-specific GPO, is pleased to announce it has entered into an exclusive contract with Stratis Medical, Inc., one of the nation's leading distributors of . . .
Posted on 7/12/18
OhioHealth and Select Medical Expand Joint Venture to Operate Physical Therapy Centers in Central Ohio
Select Medical today announced an expansion of its joint venture agreement with OhioHealth to combine operations of 38 physical therapy centers throughout Central Ohio. The partnership . . .
Posted on 7/10/18
Azalea Health Announces Partnership with Iron Bridge for All Public Health Submissions
ATLANTA & PITTSBURGH--(BUSINESS WIRE)--Azalea Health, a leading provider of fully-integrated cloud-based healthcare solutions and services, today announced it has partnered with Iron Bridge Corporation (“Iron Bridge”) . . .
Posted on 7/9/18
Is Inovio Pharmaceuticals, Inc. a Buy?
Over the last 10 years, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) stock has generated a total return to investors of 2.8%. That performance is definitely underwhelming, to say . . .
Posted on 7/3/18
Neuronetics Closes IPO
MALVERN, Pa., July 02, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc., a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve the quality . . .
Posted on 7/3/18
Optinose Named a 2018 Best Place to Work by Philadelphia Business Journal
YARDLEY, Pa., July 02, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, . . .
Posted on 6/27/18
Eight Genesis HealthCare Centers Earn 2018 Bronze National Quality Awards
KENNETT SQUARE, Pa., June 27, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare, one of the largest post-acute care providers in the United States, today announced that eight . . .
Posted on 6/27/18
Saladax Signs Licensing Agreement with Janssen
BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels for adherence and medication management, has signed a license agreement with . . .
Posted on 6/26/18
Ebb Therapeutics Wins Silver at the Prestigious MDEA Awards
Earlier this month, medtech start-up Ebb Therapeuticswas recognized with a Silver Medal at the Medical Design Excellence Awards (MDEA). The company was the only manufacturer honored . . .
Posted on 7/13/18
Interview with Scott Applebaum, President of Context Therapeutics - Part III
Brought to you by Newmark Knight Frank

